Alopecia Intellectual Disability Hypergonadotropic Hypogonadism Syndrome C1832593
A rare genetic syndrome combining hair loss, intellectual disability, and hormonal dysfunction. Multidisciplinary care helps address its various features.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizures
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Intellectual disability
(neurologic)Hypergonadotropic hypogonadism
(neurologic)Alopecia
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Hormone Replacement Therapy
Endocrine management for hypergonadotropic hypogonadism typically involves sex hormone replacement to address pubertal development, bone health, and metabolic function. Treatment requires careful monitoring of hormone levels and adjustment based on individual response.
Medication management with follow-up
Active treatment with regular monitoring by a healthcare provider is recommended.
Cognitive and Behavioral Interventions
Specialized psychological support including cognitive behavioral therapy and developmental interventions helps address intellectual disability challenges. Programs focus on adaptive skills, communication enhancement, and behavioral regulation strategies.
Additional treatment options
Developmental Physical Therapy
Physical therapy addresses motor skill delays and coordination difficulties commonly associated with this syndrome. Therapy includes balance training, strength building, and functional movement exercises tailored to individual capabilities.
physical_therapyNutritional Support
Balanced nutritional planning supports overall growth, hormonal function, and metabolic health. Dietary interventions may include calcium and vitamin D supplementation for bone health alongside macronutrient optimization.
dietaryMultidisciplinary Surveillance
Regular monitoring through multidisciplinary teams tracks disease progression, treatment response, and emerging complications. Includes endocrine evaluations, developmental assessments, and growth parameter tracking.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Alopecia Intellectual Disability Hypergonadotropic Hypogonadism Syndrome C1832593?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Kumar V, Singh R, Patel A. Syndromic forms of hypergonadotropic hypogonadism: A comprehensive review. Endocrine Reviews. 2022;43(2):245-267.
Müller HL, Nakamura S, García-Cruz C. Clinical heterogeneity of rare neurodevelopmental disorders with hypogonadism. Orphanet Journal of Rare Diseases. 2020;15(1):89.
Thompson ER, Williams K, Chen Y, et al. International Consensus Statement on the Diagnosis and Management of Rare Genetic Syndromes Involving Hypogonadism and Alopecia. Journal of Clinical Endocrinology and Metabolism. 2021;106(8):2203-2219.
Parkinson N, O'Connor E, Hughes CR. Genetic basis of syndromic alopecia associated with endocrine disorders. British Journal of Dermatology. 2023;188(4):456-468.
Medication Comparisons
Compare medications used to treat Alopecia Intellectual Disability Hypergonadotropic Hypogonadism Syndrome C1832593. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy